Rossari Biotech reviews capex, delays Unitop and Tristar expansion rollout
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Subscribe To Our Newsletter & Stay Updated